51632002: Fusiform dilatation (morphologic abnormality)

SNOMED CT Concept\Body structure (body structure)\Morphologically altered structure\Morphologically abnormal structure\Enlargement (morphologic abnormality)\Dilatation\Fusiform dilatation

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

85991012 Fusiform dilatation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

85992017 Fusiform ectasia en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

789553019 Fusiform dilatation (morphologic abnormality) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Fusiform dilatation	Is a	Dilatation	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fusiform bronchiectasis	Associated morphology	False	Fusiform dilatation	Inferred relationship	Some	1
Fusiform bronchiectasis	Associated morphology	True	Fusiform dilatation	Inferred relationship	Some	1
Ketamine-induced biliary dilatation is an acquired biliary tract disease caused by the abusive consumption of ketamine, which results in the fusiform dilatation of the common bile ducts (CBD) without obstructive lesions or dilatation of the intrahepatic biliary ducts. Possible manifestations of the underlying cholangiopathy include epigastric pain and impaired liver function. Severity of CBD dilatation appears to correlate with the duration of ketamine consumption and the condition has been reported to be reversible in abstinent patients.	Associated morphology	True	Fusiform dilatation	Inferred relationship	Some	2

Reference Sets